Stratec SE (SBS.DE) Stock Price
€25.85 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
4 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Stratec SE, AI stock picks, stock alerts and much more.
SBS.DE AI Stock Analysis
AI stock analysis for SBS.DE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Stratec SE (SBS.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Stratec SE (SBS.DE) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Stratec SE (SBS.DE), currently trading at €25.85, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SBS.DE
-
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally.
-
Symbol
SBS.DE
-
Market
XETRA
-
Industry
Medical - Devices
-
Market Cap
314.2M
Similar Stocks
 |
Eckert & Ziegler Strahlen- und Medizintechnik AG EUZ.DE |
€17.48 0.5% |
6 |
 |
aap Implantate AG AAQ1.DE |
€1.53 1.3% |
4 |
 |
Geratherm Medical AG GME.DE |
€3 2.6% |
7 |
 |
elexxion AG E8X.DE |
€0.153 2.3% |
6 |
 |
Abbott Laboratories ABL.DE |
€112.8 1.4% |
7 |
News
SBS.DE Alternative Data
Web Traffic
Stratec SE receives an estimated 29520 monthly visitors to stratec.com.
-
Web Traffic
29520
-
Change from Previous Month
44%
-
3 Month Change
17.2%
-
YoY Change
17.2%
Facebook Engagement
Stratec SE has engaged 10 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
10
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Youtube Subscribers
Stratec SE has 201 subscribers on its main Youtube channel, up by 0.5% over the last month.
-
Youtube Subscribers
201
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
2.6%
-
YoY Change
2.6%
Job Postings
Stratec SE currenly has an estimated 1 open job postings.
-
Job Postings
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Stratec SE has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Instagram Followers
Stratec SE has 468 Instagram Followers on its main Instagram account, up by 1.3% over the last month.
-
Instagram Followers
468
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
2%
-
YoY Change
2%
LinkedIn Employees
According to LinkedIn, Stratec SE has 392 employees, up by 1.8% over the last month.
-
LinkedIn Employees
392
-
Daily Change
1.8%
-
1 Month Change
1.8%
-
3 Month Change
1.3%
-
YoY Change
1.3%
Business Outlook
According to employee reviews, the business outlook among employees at Stratec SE is 65 out of 100 (bullish).
-
Business Outlook
65
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Stratec SE was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
SBS.DE Financials
SBS.DE Key Metrics
-
Total Revenue
€57.2M
-
Net Income
€549K
-
Earnings per Share
€0.0452
-
Free cash flow
€6.3M
-
EBITDA
€7.1M
-
EBITDA Ratio
0.123696
-
Total Assets
€450.8M
SBS.DE 2-year Revenue & Income
SBS.DE 2-year Free Cash Flow
SBS.DE Technicals
SBS.DE SMA
SBS.DE RSI
FAQ
What's the current price of Stratec SE (SBS.DE) Stock?
The price of an Stratec SE (SBS.DE) share is €25.85.
What's the market cap of Stratec SE?
The current market cap of Stratec SE is 314.2M.
Should I buy or sell SBS.DE?
Stratec SE shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Stratec SE is better viewed as a hold or accumulate position while waiting for further developments.
Is Stratec SE a good investment?
The current analysis of Stratec SE's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Stratec SE's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Stratec SE (SBS.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Stratec SE stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Stratec SE (SBS.DE) that investors often compare it to?
Stratec SE (SBS.DE) is often compared to similar stocks such as Eckert & Ziegler Strahlen- und Medizintechnik AG, aap Implantate AG, Geratherm Medical AG, elexxion AG and Abbott Laboratories.
What is the forecast for Stratec SE's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Stratec SE's stock price to be around €26.52 in 2026. Starting from the current price of €25.85, this represents a 2.6% change in price, indicating a neutral outlook for the stock.
How to buy Stratec SE (SBS.DE) Stock?
Stratec SE stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Stratec SE shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.